Skip to main content

Multiplex Immunofluorescence Histology for Immune Cell Infiltrates in Melanoma-Associated Tertiary Lymphoid Structures

  • Protocol
  • First Online:
Melanoma

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2265))

Abstract

The presence of tertiary lymphoid structures (TLS) is correlated with prolonged patient survival in a variety of solid cancers, including melanoma. However, few methods have been described that could enable a more comprehensive understanding of the organization and functionality of TLS in solid cancers. In this chapter, we describe multiplex immunohistochemistry and microscopy approaches for identifying, characterizing, and quantifying TLS and intra-tumoral immune infiltrates in melanoma. The described methods are not limited to melanoma alone and could be used to evaluate tertiary lymphoid structures in a wide variety of human cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dieu-Nosjean MC, Goc J, Giraldo NA, Sautes-Fridman C, Fridman WH (2014) Tertiary lymphoid structures in cancer and beyond. Trends Immunol 35(11):571–580. https://doi.org/10.1016/j.it.2014.09.006

    Article  CAS  PubMed  Google Scholar 

  2. Cabrita R, Lauss M, Sanna A, Donia M, Skaarup Larsen M, Mitra S, Johansson I, Phung B, Harbst K, Vallon-Christersson J, van Schoiack A, Lovgren K, Warren S, Jirstrom K, Olsson H, Pietras K, Ingvar C, Isaksson K, Schadendorf D, Schmidt H, Bastholt L, Carneiro A, Wargo JA, Svane IM, Jonsson G (2020) Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577(7791):561–565. https://doi.org/10.1038/s41586-019-1914-8

    Article  CAS  PubMed  Google Scholar 

  3. Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, Gopalakrishnan V, Xi Y, Zhao H, Amaria RN, Tawbi HA, Cogdill AP, Liu W, LeBleu VS, Kugeratski FG, Patel S, Davies MA, Hwu P, Lee JE, Gershenwald JE, Lucci A, Arora R, Woodman S, Keung EZ, Gaudreau PO, Reuben A, Spencer CN, Burton EM, Haydu LE, Lazar AJ, Zapassodi R, Hudgens CW, Ledesma DA, Ong S, Bailey M, Warren S, Rao D, Krijgsman O, Rozeman EA, Peeper D, Blank CU, Schumacher TN, Butterfield LH, Zelazowska MA, McBride KM, Kalluri R, Allison J, Petitprez F, Fridman WH, Sautes-Fridman C, Hacohen N, Rezvani K, Sharma P, Tetzlaff MT, Wang L, Wargo JA (2020) B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577(7791):549–555. https://doi.org/10.1038/s41586-019-1922-8

    Article  CAS  PubMed  Google Scholar 

  4. Petitprez F, de Reynies A, Keung EZ, Chen TW, Sun CM, Calderaro J, Jeng YM, Hsiao LP, Lacroix L, Bougouin A, Moreira M, Lacroix G, Natario I, Adam J, Lucchesi C, Laizet YH, Toulmonde M, Burgess MA, Bolejack V, Reinke D, Wani KM, Wang WL, Lazar AJ, Roland CL, Wargo JA, Italiano A, Sautes-Fridman C, Tawbi HA, Fridman WH (2020) B cells are associated with survival and immunotherapy response in sarcoma. Nature 577(7791):556–560. https://doi.org/10.1038/s41586-019-1906-8

    Article  CAS  PubMed  Google Scholar 

  5. Engelhard VH, Rodriguez AB, Mauldin IS, Woods AN, Peske JD, Slingluff CL Jr (2018) Immune cell infiltration and tertiary lymphoid structures as determinants of antitumor immunity. J Immunol 200(2):432–442. https://doi.org/10.4049/jimmunol.1701269

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Goc J, Fridman WH, Sautes-Fridman C, Dieu-Nosjean MC (2013) Characteristics of tertiary lymphoid structures in primary cancers. Onco Targets Ther 2(12):e26836. https://doi.org/10.4161/onci.26836

    Article  Google Scholar 

  7. Germain C, Gnjatic S, Dieu-Nosjean MC (2015) Tertiary lymphoid structure-associated B cells are key players in anti-tumor immunity. Front Immunol 6:67. https://doi.org/10.3389/fimmu.2015.00067

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Barua S, Fang P, Sharma A, Fujimoto J, Wistuba I, Rao AUK, Lin SH (2018) Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer. Lung Cancer 117:73–79. https://doi.org/10.1016/j.lungcan.2018.01.022

    Article  PubMed  PubMed Central  Google Scholar 

  9. Mezheyeuski A, Bergsland CH, Backman M, Djureinovic D, Sjoblom T, Bruun J, Micke P (2018) Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients. J Pathol 244(4):421–431. https://doi.org/10.1002/path.5026

    Article  CAS  PubMed  Google Scholar 

  10. Zhao H, Liao XL, Kang Y (2017) Tregs: where we are and what comes next? Front Immunol 8:1578. https://doi.org/10.3389/fimmu.2017.01578

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Sun XM, Kaufman PD (2018) Ki-67: more than a proliferation marker. Chromosoma 127(2):175–186. https://doi.org/10.1007/s00412-018-0659-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Wada Y, Nakashima O, Kutami R, Yamamoto O, Kojiro M (1998) Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 27(2):407–414. https://doi.org/10.1002/hep.510270214

    Article  CAS  PubMed  Google Scholar 

  13. Silina K, Soltermann A, Attar FM, Casanova R, Uckeley ZM, Thut H, Wandres M, Isajevs S, Cheng P, Curioni-Fontecedro A, Foukas P, Levesque MP, Moch H, Line A, van den Broek M (2018) Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma. Cancer Res 78(5):1308–1320. https://doi.org/10.1158/0008-5472.CAN-17-1987

    Article  CAS  PubMed  Google Scholar 

  14. Posch F, Silina K, Leibl S, Mundlein A, Moch H, Siebenhuner A, Samaras P, Riedl J, Stotz M, Szkandera J, Stoger H, Pichler M, Stupp R, van den Broek M, Schraml P, Gerger A, Petrausch U, Winder T (2018) Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer. Onco Targets Ther 7(2):e1378844. https://doi.org/10.1080/2162402X.2017.1378844

    Article  Google Scholar 

  15. Keim C, Kazadi D, Rothschild G, Basu U (2013) Regulation of AID, the B-cell genome mutator. Genes Dev 27(1):1–17. https://doi.org/10.1101/gad.200014.112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Lossos IS, Levy R, Alizadeh AA (2004) AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity. Leukemia 18(11):1775–1779. https://doi.org/10.1038/sj.leu.2403488

    Article  CAS  PubMed  Google Scholar 

  17. Dejean AS, Joulia E, Walzer T (2019) The role of Eomes in human CD4 T cell differentiation: a question of context. Eur J Immunol 49(1):38–41. https://doi.org/10.1002/eji.201848000

    Article  CAS  PubMed  Google Scholar 

  18. Evans CM, Jenner RG (2013) Transcription factor interplay in T helper cell differentiation. Brief Funct Genomics 12(6):499–511. https://doi.org/10.1093/bfgp/elt025

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Zhu Y, Ju S, Chen E, Dai S, Li C, Morel P, Liu L, Zhang X, Lu B (2010) T-bet and eomesodermin are required for T cell-mediated antitumor immune responses. J Immunol 185(6):3174–3183. https://doi.org/10.4049/jimmunol.1000749

    Article  CAS  PubMed  Google Scholar 

  20. Pearce EL, Mullen AC, Martins GA, Krawczyk CM, Hutchins AS, Zediak VP, Banica M, DiCioccio CB, Gross DA, Mao CA, Shen H, Cereb N, Yang SY, Lindsten T, Rossant J, Hunter CA, Reiner SL (2003) Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302(5647):1041–1043. https://doi.org/10.1126/science.1090148

    Article  CAS  PubMed  Google Scholar 

  21. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pages F (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795):1960–1964. https://doi.org/10.1126/science.1129139

    Article  CAS  PubMed  Google Scholar 

  22. Li J, He Y, Hao J, Ni L, Dong C (2018) High levels of Eomes promote exhaustion of anti-tumor CD8(+) T cells. Front Immunol 9:2981. https://doi.org/10.3389/fimmu.2018.02981

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Shitara K, Nishikawa H (2018) Regulatory T cells: a potential target in cancer immunotherapy. Ann N Y Acad Sci 1417(1):104–115. https://doi.org/10.1111/nyas.13625

    Article  CAS  PubMed  Google Scholar 

  24. Magnuson AM, Kiner E, Ergun A, Park JS, Asinovski N, Ortiz-Lopez A, Kilcoyne A, Paoluzzi-Tomada E, Weissleder R, Mathis D, Benoist C (2018) Identification and validation of a tumor-infiltrating Treg transcriptional signature conserved across species and tumor types. Proc Natl Acad Sci U S A 115(45):E10672–E10681. https://doi.org/10.1073/pnas.1810580115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Shang B, Liu Y, Jiang SJ, Liu Y (2015) Prognostic value of tumor-infiltrating FoxP3(+) regulatory T cells in cancers: a systematic review and meta-analysis. Sci Rep 5:15179. https://doi.org/10.1038/srep15179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gao AQ, Sun YP, Peng GY (2018) ILT4 functions as a potential checkpoint molecule for tumor immunotherapy. BBA Rev Cancer 1869(2):278–285. https://doi.org/10.1016/j.bbcan.2018.04.001

    Article  CAS  Google Scholar 

  27. Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182(3):311–322. https://doi.org/10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Funding: This work was supported by the University of Virginia Cancer Center (NIH P30 CA044579, Biorepository and Tissue Research Facility, Molecular and Immunologic Translational Science Core).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ileana S. Mauldin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Mauldin, I.S., Mahmutovic, A., Young, S.J., Slingluff, C.L. (2021). Multiplex Immunofluorescence Histology for Immune Cell Infiltrates in Melanoma-Associated Tertiary Lymphoid Structures. In: Hargadon, K.M. (eds) Melanoma. Methods in Molecular Biology, vol 2265. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1205-7_40

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-1205-7_40

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-1204-0

  • Online ISBN: 978-1-0716-1205-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics